Kirk Kaminsky is President of U.S. Pharmaceutical for McKesson Corporation. Kirk is responsible for providing leadership and strategic direction for McKesson’s best-in-class wholesale drug distribution and value-added technology solutions for retail pharmacies, health systems, payers and community providers in the U.S. Kirk also leads the development of the company’s oncology ecosystem, a strategic growth pillar, through The US Oncology Network, Sarah Cannon Research Institute, Ontada and Biologics by McKesson specialty pharmacy. Kirk joined McKesson in 2003 and has served in a variety of leadership roles at the company. Most recently, Kirk headed the Specialty Provider Organization, a division of U.S. Pharmaceutical and served as President of The US Oncology Network, led the U.S. Pharmaceutical packaging business and was a member of the company’s Corporate Strategy and Business Development function. Prior to joining McKesson, Kirk worked in investment banking as a financial analyst, concentrating on corporate finance for healthcare and consumer retail. Kirk holds a Bachelor of Arts in Economics for Business from Occidental College a Master of Business Administration from The Wharton School.
